Cargando…
Evaluation of Plan Robustness Using Hybrid Intensity-Modulated Radiotherapy (IMRT) and Volumetric Arc Modulation Radiotherapy (VMAT) for Left-Sided Breast Cancer
Purpose: We aim to evaluate the robustness of multi-field IMRT and VMAT plans to target motion for left-sided BC radiotherapy. Methods: The 7-field hybrid IMRT (7F-H-IMRT) and 2-arc VMAT (2A-VMAT) plans were generated for ten left-sided BC patients. Shifts of 3 mm, 5 mm, and 10 mm in six directions...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9028731/ https://www.ncbi.nlm.nih.gov/pubmed/35447691 http://dx.doi.org/10.3390/bioengineering9040131 |
_version_ | 1784691695783247872 |
---|---|
author | Ding, Zhen Zeng, Qi Kang, Kailian Xu, Meiling Xiang, Xiaoyong Liu, Chenbin |
author_facet | Ding, Zhen Zeng, Qi Kang, Kailian Xu, Meiling Xiang, Xiaoyong Liu, Chenbin |
author_sort | Ding, Zhen |
collection | PubMed |
description | Purpose: We aim to evaluate the robustness of multi-field IMRT and VMAT plans to target motion for left-sided BC radiotherapy. Methods: The 7-field hybrid IMRT (7F-H-IMRT) and 2-arc VMAT (2A-VMAT) plans were generated for ten left-sided BC patients. Shifts of 3 mm, 5 mm, and 10 mm in six directions were introduced and the perturbed dose distributions were recalculated. The dose differences (∆D) of the original plan and perturbed plan corresponded to the plan robustness for the structure. Results: Higher ∆D(98%), ∆D(95%), and ∆D(mean) of CTV were observed in 2A-VMAT plans, which induced higher tumor control probability reductions. A higher ∆Dmean of CTV Boost was found in 7F-H-IMRT plans despite lower ∆D(98%) and ∆D(95%). Shifts in the S-I direction exerted the largest effect on CTV and CTV Boost. Regarding OARs, shifts in R, P, and I directions contributed to increasing the received dose. The 2A-VMAT plans performed better dose sparing, but had a higher robustness in a high-dose volume of the left lung and heart. The 2A-VMAT plans decreased the max dose of LAD but exhibited lower robustness. Conclusion: The 2A-VMAT plans showed higher sensitivity to position deviation. Shifts in the S-I direction exerted the largest effect for CTV and CTV Boost. |
format | Online Article Text |
id | pubmed-9028731 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-90287312022-04-23 Evaluation of Plan Robustness Using Hybrid Intensity-Modulated Radiotherapy (IMRT) and Volumetric Arc Modulation Radiotherapy (VMAT) for Left-Sided Breast Cancer Ding, Zhen Zeng, Qi Kang, Kailian Xu, Meiling Xiang, Xiaoyong Liu, Chenbin Bioengineering (Basel) Article Purpose: We aim to evaluate the robustness of multi-field IMRT and VMAT plans to target motion for left-sided BC radiotherapy. Methods: The 7-field hybrid IMRT (7F-H-IMRT) and 2-arc VMAT (2A-VMAT) plans were generated for ten left-sided BC patients. Shifts of 3 mm, 5 mm, and 10 mm in six directions were introduced and the perturbed dose distributions were recalculated. The dose differences (∆D) of the original plan and perturbed plan corresponded to the plan robustness for the structure. Results: Higher ∆D(98%), ∆D(95%), and ∆D(mean) of CTV were observed in 2A-VMAT plans, which induced higher tumor control probability reductions. A higher ∆Dmean of CTV Boost was found in 7F-H-IMRT plans despite lower ∆D(98%) and ∆D(95%). Shifts in the S-I direction exerted the largest effect on CTV and CTV Boost. Regarding OARs, shifts in R, P, and I directions contributed to increasing the received dose. The 2A-VMAT plans performed better dose sparing, but had a higher robustness in a high-dose volume of the left lung and heart. The 2A-VMAT plans decreased the max dose of LAD but exhibited lower robustness. Conclusion: The 2A-VMAT plans showed higher sensitivity to position deviation. Shifts in the S-I direction exerted the largest effect for CTV and CTV Boost. MDPI 2022-03-24 /pmc/articles/PMC9028731/ /pubmed/35447691 http://dx.doi.org/10.3390/bioengineering9040131 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Ding, Zhen Zeng, Qi Kang, Kailian Xu, Meiling Xiang, Xiaoyong Liu, Chenbin Evaluation of Plan Robustness Using Hybrid Intensity-Modulated Radiotherapy (IMRT) and Volumetric Arc Modulation Radiotherapy (VMAT) for Left-Sided Breast Cancer |
title | Evaluation of Plan Robustness Using Hybrid Intensity-Modulated Radiotherapy (IMRT) and Volumetric Arc Modulation Radiotherapy (VMAT) for Left-Sided Breast Cancer |
title_full | Evaluation of Plan Robustness Using Hybrid Intensity-Modulated Radiotherapy (IMRT) and Volumetric Arc Modulation Radiotherapy (VMAT) for Left-Sided Breast Cancer |
title_fullStr | Evaluation of Plan Robustness Using Hybrid Intensity-Modulated Radiotherapy (IMRT) and Volumetric Arc Modulation Radiotherapy (VMAT) for Left-Sided Breast Cancer |
title_full_unstemmed | Evaluation of Plan Robustness Using Hybrid Intensity-Modulated Radiotherapy (IMRT) and Volumetric Arc Modulation Radiotherapy (VMAT) for Left-Sided Breast Cancer |
title_short | Evaluation of Plan Robustness Using Hybrid Intensity-Modulated Radiotherapy (IMRT) and Volumetric Arc Modulation Radiotherapy (VMAT) for Left-Sided Breast Cancer |
title_sort | evaluation of plan robustness using hybrid intensity-modulated radiotherapy (imrt) and volumetric arc modulation radiotherapy (vmat) for left-sided breast cancer |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9028731/ https://www.ncbi.nlm.nih.gov/pubmed/35447691 http://dx.doi.org/10.3390/bioengineering9040131 |
work_keys_str_mv | AT dingzhen evaluationofplanrobustnessusinghybridintensitymodulatedradiotherapyimrtandvolumetricarcmodulationradiotherapyvmatforleftsidedbreastcancer AT zengqi evaluationofplanrobustnessusinghybridintensitymodulatedradiotherapyimrtandvolumetricarcmodulationradiotherapyvmatforleftsidedbreastcancer AT kangkailian evaluationofplanrobustnessusinghybridintensitymodulatedradiotherapyimrtandvolumetricarcmodulationradiotherapyvmatforleftsidedbreastcancer AT xumeiling evaluationofplanrobustnessusinghybridintensitymodulatedradiotherapyimrtandvolumetricarcmodulationradiotherapyvmatforleftsidedbreastcancer AT xiangxiaoyong evaluationofplanrobustnessusinghybridintensitymodulatedradiotherapyimrtandvolumetricarcmodulationradiotherapyvmatforleftsidedbreastcancer AT liuchenbin evaluationofplanrobustnessusinghybridintensitymodulatedradiotherapyimrtandvolumetricarcmodulationradiotherapyvmatforleftsidedbreastcancer |